Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
HollisS. Kezar$suffix/text()$suffix/text(), J.
Michael Kilpatrick, Deborah Phillips, Debbie Kellogg, Jianwen Zhang & PhilipE. Morris$suffix/text()$suffix/text(). (2005) Synthesis and Pharmacokinetic and Pharmacodynamic Evaluation of the Forodesine HCl Analog BCX-3040. Nucleosides, Nucleotides & Nucleic Acids 24:10-12, pages 1817-1830.
Read now
Read now
Vern
L. Schramm. (2004) Immucillins as Antibiotics for T‐Cell Proliferation and Malaria. Nucleosides, Nucleotides & Nucleic Acids 23:8-9, pages 1305-1311.
Read now
Read now
PhilipE. Morris$suffix/text()$suffix/text(), ArthurJ. Elliott, SandraP. Walton, CarlH. Williams & JohnA. Montgomery. (2000) Synthesis and Biological Activity of a Novel Class of Purine Nucleoside Phosphorylase Inhibitors. Nucleosides, Nucleotides & Nucleic Acids 19:1-2, pages 379-404.
Read now
Read now
Articles from other publishers (15)
Jan Skácel, Stefan Djukic, Ondřej Baszczyňski, Filip Kalčic, Tadeáš Bílek, Karel Chalupský, Jaroslav Kozák, Alexandra Dvořáková, Eva Tloušt’ová, Zuzana Král’ová, Markéta Šmídková, Jan Voldřich, Michaela Rumlová, Petr Pachl, Jiří Brynda, Tereza Vučková, Milan Fábry, Jan Snášel, Iva Pichová, Pavlína Řezáčová, Helena Mertlíková-Kaiserová & Zlatko Janeba. (2023) Design, Synthesis, Biological Evaluation, and Crystallographic Study of Novel Purine Nucleoside Phosphorylase Inhibitors. Journal of Medicinal Chemistry 66:10, pages 6652-6681.
Crossref
Crossref
Anastasia Khandazhinskaya, Ilja Fateev, Irina Konstantinova, Roman Esipov, Konstantin Polyakov, Katherine Seley-Radtke, Sergey Kochetkov & Elena Matyugina. (2022) Synthesis of New 5′-Norcarbocyclic Aza/Deaza Purine Fleximers - Noncompetitive Inhibitors of E.coli Purine Nucleoside Phosphorylase. Frontiers in Chemistry 10.
Crossref
Crossref
Vern L. Schramm. (2018) Enzymatic Transition States and Drug Design. Chemical Reviews 118:22, pages 11194-11258.
Crossref
Crossref
Richard B. Silverman & Mark W. Holladay. 2014. The Organic Chemistry of Drug Design and Drug Action. The Organic Chemistry of Drug Design and Drug Action
207
274
.
Vivekanand P. Kamath, Jesus J. Juarez-Brambila & Philip E. MorrisJrJr. (2009) Synthesis of labeled BCX-4208, a potent inhibitor of purine nucleoside phosphorylase. Drug Testing and Analysis 1:3, pages 125-127.
Crossref
Crossref
Gary B. Evans, Richard H. Furneaux, Ben Greatrex, Andrew S. Murkin, Vern L. Schramm & Peter C. Tyler. (2008)
Azetidine Based Transition State Analogue Inhibitors of
N
-Ribosyl Hydrolases and Phosphorylases
. Journal of Medicinal Chemistry 51:4, pages 948-956.
Crossref
Crossref
Gary B. Evans. (2004) The Synthesis of N-Ribosyl Transferase Inhibitors Based on a Transition State Blueprint. Australian Journal of Chemistry 57:9, pages 837.
Crossref
Crossref
J.Michael Kilpatrick, Philip E. Morris, David G. SerotaJr.Jr., Deborah Phillips, D.Ray MooreIIII, J.Claude Bennett & Y.S. Babu. (2003) Intravenous and oral pharmacokinetic study of BCX-1777, a novel purine nucleoside phosphorylase transition-state inhibitor. In vivo effects on blood 2′-deoxyguanosine in primates. International Immunopharmacology 3:4, pages 541-548.
Crossref
Crossref
Vern L Schramm. (2002) Development of transition state analogues of purine nucleoside phosphorylase as anti-T-cell agents. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1587:2-3, pages 107-117.
Crossref
Crossref
Hollis S. KezarIIIIII, Tracy L. Hutchison, Peter C. Tyler & Philip E. MorrisJr.Jr.. (2001) Synthesis of deuterated‐BCX‐1777, a potent inhibitor of purine nucleoside phosphorylase. Journal of Labelled Compounds and Radiopharmaceuticals 45:1, pages 71-78.
Crossref
Crossref
Greg A. Kicska, Li Long, Heidi Hörig, Craig Fairchild, Peter C. Tyler, Richard H. Furneaux, Vern L. Schramm & Howard L. Kaufman. (2001) Immucillin H, a powerful transition-state analog inhibitor of purine nucleoside phosphorylase, selectively inhibits human T lymphocytes. Proceedings of the National Academy of Sciences 98:8, pages 4593-4598.
Crossref
Crossref
Adriano D. ANDRICOPULO & Rosendo A. YUNES. (2001) Structure-Activity Relationships for a Collection of Structurally Diverse Inhibitors of Purine Nucleoside Phosphorylase.. Chemical and Pharmaceutical Bulletin 49:1, pages 10-17.
Crossref
Crossref
C. J. D. Sinclair, C. G. LaRivière, James D. Young, Carol E. Cass, Stephen A. Baldwin & F. E. Parkinson. (2002) Purine Uptake and Release in Rat C6 Glioma Cells. Journal of Neurochemistry 75:4, pages 1528-1538.
Crossref
Crossref
Michael D. Sintchak & Elmar Nimmesgern. (2000) The structure of inosine 5′-monophosphate dehydrogenase and the design of novel inhibitors. Immunopharmacology 47:2-3, pages 163-184.
Crossref
Crossref
Fang Wang, Robert W. Miles, Gregory Kicska, Edward Nieves, Vern L. Schramm & Ruth Hogue Angeletti. (2008) Immucillin‐H binding to purine nucleoside phosphorylase reduces dynamic solvent exchange. Protein Science 9:9, pages 1660-1668.
Crossref
Crossref